FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984138372> ?p ?o ?g. }

• W1984138372 endingPage "57" @default.
• W1984138372 startingPage "47" @default.
• W1984138372 abstract "This is the final report of a large, controlled, multicenter Italian study on immuno- and chemotherapy in adult patients with burns affecting 20 to 95% of total body surface area (mean 35%). The antibiotic treatment of burn patients consisted of topical silver sulfadiazine, short-term antimicrobial chemoprophylaxis with pefloxacin (800 mg i.v. qd) for the first 4 days and polychemotherapy with teicoplanin (800 mg i.v. qd) together with netilmicin (300 mg i.m. qd) in one or more cycles of 5-12 days. At random, half of the patients received thymostimulin, 70 mg i.m. qd for the first month and every other day thereafter.The analysis at completion of 634 valid cases showed that when the results are stratified by means of the Roi risk index, 396 of the 530 patients who contracted wound infection (84%) after chemoprophylaxis were in the first three categories and a mean of 95% survived. Of the remaining 134 patients (Roi index 4-5) only 50% survived.There was no difference in survival of the immunotherapy group in comparison with the parallel group without thymostimulin. The short-term antimicrobial prophylaxis prevented wound infection in only 104 of 634 patients (16%) and they were at low risk (84% Roi index 1).Of the bacterial pathogens involved in septic complications Staphylococcus aureus and Pseudomonas aeruginosa were prevalent (86%): eradication was achieved in 43% of patients and clinical cure or improvement were seen with combination chemotherapy in 64% of all patients, mainly with only one treatment cycle. This value increased to 79% for the 395 protocol-complying patients and went down to 20% in the 135 non-compliers. The total survival of complier and non-complier patients was 447 of the 530 valid patients (84%).The overall mortality of the 634 evaluable patients was 13.1%, ranging from less than 2% to 68%. Burn mortality was directly proportional to the percentage of burned body surface area, to increasing age and other variables of the Roi index, a 50% mortality being associated with a 72.5% total body surface area burned. Normoergic burn patients had a mortality rate of 9.1% versus 35.7% in anergic patients." @default.
• W1984138372 created "2016-06-24" @default.
• W1984138372 creator A5001803987 @default.
• W1984138372 creator A5005549319 @default.
• W1984138372 creator A5005955741 @default.
• W1984138372 creator A5008754952 @default.
• W1984138372 creator A5016800579 @default.
• W1984138372 creator A5048427880 @default.
• W1984138372 creator A5049637687 @default.
• W1984138372 creator A5051728890 @default.
• W1984138372 creator A5059372961 @default.
• W1984138372 creator A5061125722 @default.
• W1984138372 creator A5063731389 @default.
• W1984138372 creator A5073530079 @default.
• W1984138372 creator A5083589153 @default.
• W1984138372 creator A5089100890 @default.
• W1984138372 date "1998-01-01" @default.
• W1984138372 modified "2023-10-14" @default.
• W1984138372 title "Increased Burn Patient Survival with Once-A-Day High Dose Teicoplanin and Netilmicin. An Italian Multicenter Study" @default.
• W1984138372 cites W125149577 @default.
• W1984138372 cites W163622122 @default.
• W1984138372 cites W1985993140 @default.
• W1984138372 cites W2017994115 @default.
• W1984138372 cites W2023571395 @default.
• W1984138372 cites W2034052812 @default.
• W1984138372 cites W2046598970 @default.
• W1984138372 cites W2068775691 @default.
• W1984138372 cites W2069068974 @default.
• W1984138372 cites W2077348702 @default.
• W1984138372 cites W2080074588 @default.
• W1984138372 cites W2082604520 @default.
• W1984138372 cites W2092416260 @default.
• W1984138372 cites W2094181805 @default.
• W1984138372 cites W2339568456 @default.
• W1984138372 cites W2340827624 @default.
• W1984138372 cites W4235346983 @default.
• W1984138372 doi "https://doi.org/10.1179/joc.1998.10.1.47" @default.
• W1984138372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9531075" @default.
• W1984138372 hasPublicationYear "1998" @default.
• W1984138372 type Work @default.
• W1984138372 sameAs 1984138372 @default.
• W1984138372 citedByCount "6" @default.
• W1984138372 countsByYear W19841383722013 @default.
• W1984138372 countsByYear W19841383722016 @default.
• W1984138372 countsByYear W19841383722020 @default.
• W1984138372 crossrefType "journal-article" @default.
• W1984138372 hasAuthorship W1984138372A5001803987 @default.
• W1984138372 hasAuthorship W1984138372A5005549319 @default.
• W1984138372 hasAuthorship W1984138372A5005955741 @default.
• W1984138372 hasAuthorship W1984138372A5008754952 @default.
• W1984138372 hasAuthorship W1984138372A5016800579 @default.
• W1984138372 hasAuthorship W1984138372A5048427880 @default.
• W1984138372 hasAuthorship W1984138372A5049637687 @default.
• W1984138372 hasAuthorship W1984138372A5051728890 @default.
• W1984138372 hasAuthorship W1984138372A5059372961 @default.
• W1984138372 hasAuthorship W1984138372A5061125722 @default.
• W1984138372 hasAuthorship W1984138372A5063731389 @default.
• W1984138372 hasAuthorship W1984138372A5073530079 @default.
• W1984138372 hasAuthorship W1984138372A5083589153 @default.
• W1984138372 hasAuthorship W1984138372A5089100890 @default.
• W1984138372 hasConcept C126322002 @default.
• W1984138372 hasConcept C141071460 @default.
• W1984138372 hasConcept C2775832221 @default.
• W1984138372 hasConcept C2776532303 @default.
• W1984138372 hasConcept C2776688490 @default.
• W1984138372 hasConcept C2776694085 @default.
• W1984138372 hasConcept C2776703206 @default.
• W1984138372 hasConcept C2778269047 @default.
• W1984138372 hasConcept C2778974779 @default.
• W1984138372 hasConcept C2778977604 @default.
• W1984138372 hasConcept C2778980435 @default.
• W1984138372 hasConcept C2779489039 @default.
• W1984138372 hasConcept C2780269544 @default.
• W1984138372 hasConcept C501593827 @default.
• W1984138372 hasConcept C523546767 @default.
• W1984138372 hasConcept C54355233 @default.
• W1984138372 hasConcept C71924100 @default.
• W1984138372 hasConcept C86803240 @default.
• W1984138372 hasConcept C89423630 @default.
• W1984138372 hasConcept C90924648 @default.
• W1984138372 hasConceptScore W1984138372C126322002 @default.
• W1984138372 hasConceptScore W1984138372C141071460 @default.
• W1984138372 hasConceptScore W1984138372C2775832221 @default.
• W1984138372 hasConceptScore W1984138372C2776532303 @default.
• W1984138372 hasConceptScore W1984138372C2776688490 @default.
• W1984138372 hasConceptScore W1984138372C2776694085 @default.
• W1984138372 hasConceptScore W1984138372C2776703206 @default.
• W1984138372 hasConceptScore W1984138372C2778269047 @default.
• W1984138372 hasConceptScore W1984138372C2778974779 @default.
• W1984138372 hasConceptScore W1984138372C2778977604 @default.
• W1984138372 hasConceptScore W1984138372C2778980435 @default.
• W1984138372 hasConceptScore W1984138372C2779489039 @default.
• W1984138372 hasConceptScore W1984138372C2780269544 @default.
• W1984138372 hasConceptScore W1984138372C501593827 @default.
• W1984138372 hasConceptScore W1984138372C523546767 @default.
• W1984138372 hasConceptScore W1984138372C54355233 @default.
• W1984138372 hasConceptScore W1984138372C71924100 @default.
• W1984138372 hasConceptScore W1984138372C86803240 @default.

• next